- Gentlemen, start your drones: Judge’s ruling opens door for commercial use
- Soldier who hid, bragged about not saluting flag to be punished — in secret
- ‘Maverick’ of the seas: ‘Top Gun’ school for U.S. ship officers to launch
- Putin declares Sochi Paralympics open amid Ukrainian protest
- ‘In Jesus name, we pray’ sparks ire at Ohio council meeting
- Navy’s first laser weapon ready for prime time; drone killer to deploy this summer
- Billionaire backer: Rick Santorum ‘needs to be heard’ in 2016
- Obamacare fallout: 49 percent pessimistic; 45 percent ‘scared’
- DHS accused of holding U.S. citizen at airport, using emails to pry into her sex life
- Seattle socialist: Minimum-wage discussion skewed by ‘right-wing’ GAO analysis
Taxpayers must pay the freight for over-budget train projects
Topic - Mark Silverman
Pfizer Inc.'s just-approved Xalkori, the first new medicine in several years for deadly lung cancer, shows the value of a new research standard: precisely targeting rare diseases linked to gene variants.
One of Kay Monigold's first big headaches when she bought a small cable TV business in Illinois and Indiana in late 2007 was a startup cable channel specializing in Big Ten sports.
"It was really just this great combination of assets," Silverman said. "It really just enabled us to succeed."
"That's just not the way the conference works _ I would imagine that would have caused issues," he said, noting that a big reason his network works well for the conference is that the schools _ from top dogs Ohio State and Michigan all the way down to Indiana and Purdue _ share the money equally.